The rise in the number of chronic obstructive pulmonary disease patients (COPD), tuberculosis, asthma, and pneumonia cases remains the major driver of the industry. Chronic respiratory diseases are chronic diseases that affect the airways and other parts of the lungs. According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) and asthma are among the most common respiratory diseases affecting people worldwide. According to the Saudi Thoracic Society, in 2018, the prevalence of the chronic obstructive pulmonary disease in Saudi Arabia was 4.2% among the general population and 14.2% among smokers. The need to treat a large population, reduce the number of deaths, and prevent the diseases from spreading further, and therefore is attributed to the increasing demand for respiratory devices across the country.
Key Market Trends
Spirometers Segment is Expected to Show Better Growth Over the Forecast Period
Based on the diagnostic and monitoring devices segment, it is categorized into spirometers, sleep test devices, peak flow meters, pulse oximeters, capnography, and others. The main factor attributing to the growth of the spirometers segment is the increasing burden of respiratory disorders, such as asthma, bronchitis, and COPD across the country. The wide application of spirometers makes it easier for the patient to use this device and is thus, increasingly adopted in hospitals and home care settings. Furthermore, the significant advancements in the field of spirometry include the development of small portable spirometers and the increasing accuracy and acceptability, which is expected to fuel the market growth over the forecast period.
Competitive Landscape
The global players into the Saudi Arabia respiratory devices market are Dragerwerk AG, Fisher & Paykel Healthcare Limited, GE Healthcare, GlaxoSmithKline PLC, Invacare Corporation, Koninklijke Philips N.V, Medtronic PLC and ResMed Inc.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support